|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0011849,
umls-concept:C0021107,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0055729,
umls-concept:C0087111,
umls-concept:C0205087,
umls-concept:C0205174,
umls-concept:C0332283,
umls-concept:C0333186,
umls-concept:C0392756,
umls-concept:C1322815,
umls-concept:C1554184,
umls-concept:C1707455,
umls-concept:C2348535
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2008-3-21
|
|
pubmed:abstractText |
We sought to evaluate the impact of cilostazol on neointimal hyperplasia after drug-eluting stent (DES) implantation in patients with diabetes mellitus (DM).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1558-3597
|
|
pubmed:author |
pubmed-author:ChoYoon HaengYH,
pubmed-author:ChoiSi WanSW,
pubmed-author:ChunKook-JinKJ,
pubmed-author:HongMyeong-KiMK,
pubmed-author:KimHyun-SookHS,
pubmed-author:KimJune HongJH,
pubmed-author:KimYoung-HakYH,
pubmed-author:KoJae-KiJK,
pubmed-author:LeeCheol WhanCW,
pubmed-author:LeeJae-HwanJH,
pubmed-author:LeeNae-HeeNH,
pubmed-author:LeeSeung-WhanSW,
pubmed-author:ParkDuk-WooDW,
pubmed-author:ParkJae-HyeongJH,
pubmed-author:ParkSeong-WookSW,
pubmed-author:ParkSeung-JungSJ,
pubmed-author:SeongIn-WhanIW,
pubmed-author:YunSung-CheolSC
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
25
|
|
pubmed:volume |
51
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1181-7
|
|
pubmed:meshHeading |
pubmed-meshheading:18355656-Aged,
pubmed-meshheading:18355656-Aspirin,
pubmed-meshheading:18355656-Coronary Angiography,
pubmed-meshheading:18355656-Coronary Artery Disease,
pubmed-meshheading:18355656-Coronary Restenosis,
pubmed-meshheading:18355656-Coronary Vessels,
pubmed-meshheading:18355656-Diabetes Mellitus,
pubmed-meshheading:18355656-Diabetic Angiopathies,
pubmed-meshheading:18355656-Drug Therapy, Combination,
pubmed-meshheading:18355656-Drug-Eluting Stents,
pubmed-meshheading:18355656-Female,
pubmed-meshheading:18355656-Humans,
pubmed-meshheading:18355656-Hyperplasia,
pubmed-meshheading:18355656-Male,
pubmed-meshheading:18355656-Middle Aged,
pubmed-meshheading:18355656-Platelet Aggregation Inhibitors,
pubmed-meshheading:18355656-Tetrazoles,
pubmed-meshheading:18355656-Ticlopidine,
pubmed-meshheading:18355656-Treatment Outcome,
pubmed-meshheading:18355656-Tunica Intima
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients).
|
|
pubmed:affiliation |
Asan Medical Center, University of Ulsan College of Medicine, Songpa-gu, Seoul, 138-736, Korea.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
